Search
Search Results
##search.searchResults.foundPlural##
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2440PDF: 1384HTML: 17215Bassan Fig.1: 178Bassan Fig.2: 283Bassan Fig.4: 169Fig.3: 253 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3758PDF: 2623HTML: 1668 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2478PDF: 1934HTML: 184 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2719PDF: 1701HTML: 2457Table1: 242 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1733PDF: 693HTML: 2450 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2039PDF: 843HTML: 603 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3927PDF: 1569HTML: 352 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3596PDF: 1457HTML: 2729 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1295PDF: 641HTML: 6935 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3904PDF: 1705HTML: 104 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3398PDF: 1551HTML: 5973Fig1-Ag-Pil: 281Ag-Pil Fig.2: 281 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4656PDF: 1806HTML: 1304 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5897PDF: 1598HTML: 1669Untitled: 277 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3570PDF: 847HTML: 3029Figure 1a and 1b: 189Figure 2: 201Figure 3: 211Figure 4: 197Figure 5: 199Tables 1-5: 177 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4093PDF: 1120HTML: 3904Untitled: 199Cneo. Fig.1: 141Untitled: 132Untitled: 159Untitled: 168 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2119PDF: 468HTML: 243 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7932PDF: 2510HTML: 2142Table 1.: 269Table 2.: 277Table 3.: 259Table 4.: 256 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1209PDF: 569HTML: 394 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
2002PDF: 734HTML: 2438Untitled: 199Figure 1 a: 198Figure 1 b: 212Fig 1 c: 192Figure 1 d: 242 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1569PDF: 907HTML: 1117Untitled: 217 -
-
Acquired Hemophilia A successfully treated with rituximab
2228PDF: 1204HTML: 1522Figure 1: 236 -
Persistent Fever and Splenic Abscess-like Lesions: A Diagnostic Trap in a Young Adult
93PDF: 74Suppl. Files: 22Html: 61Html Suppl. Files: 13 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4660PDF: 3847HTML: 378







